Hereditary Disease Foundation Transformative Research Award

Funding is available for collaborative research teams to carry out innovative projects that will provide new insights into disease mechanisms or develop therapeutic treatments relevant to Huntington’s disease.

The Hereditary Disease Foundation (HDF) is a US-based charitable organisation established in 1968. Its mission is to cure genetic disorders, notably Huntington’s disease, by supporting innovative research.

The HDF Transformative Research Award provides funding for collaborative research teams to create innovative ways to study new pathogenic disease mechanisms and treatment modalities in Huntington’s disease (HD).

General areas include but are not limited to:

• Whether modulation of somatic repeat instability is disease modifying.
• Whether and how cellular, biochemical or molecular insights in HD systems are predictive of disease.
• How to apply unexplored therapeutics for clinical application (inclusive of biomarkers).

HDF encourages projects that aim to discover disease modifying targets or incorporate novel tools or technologies.